Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: April 9th

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

SGE1

Rank: President [?]

Points: 26670 [?]

Votes: 187 Score: 3.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: April 9th - 30.5Mil plus 20Mil/yr for 7 more yrs.

in response to

Re: April 9th - 30.5Mil plus 20Mil/yr for 7 more yrs.

rosesny1

posted on Mar 06, 2008 06:01AM

Obselesence would only potentially become an issue if the ongoing payments were royalties based on the magnitude of continued use of the technology. What was proposed in the conjecture were payments of a fixed amount annually over time. Thus, obselesence would not be an issue.

JMHO,

SGE

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply